Clinical Trials Using Bcl-2/Bcl-XL Inhibitor APG-1252
Clinical trials are research studies that involve people. The clinical trials on this list are studying Bcl-2/Bcl-XL Inhibitor APG-1252. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Study of Combination APG-1252 Plus Paclitaxel in Patients With Relapsed / Refractory Small Cell Lung Cancer
A Multi-Center, Phase Ib / II Study of Combination APG-1252 plus Paclitaxel in Patients with Relapsed / Refractory Small Cell Lung Cancer (SCLC)
Location: 2 locations